JP2022533316A5 - - Google Patents
Info
- Publication number
- JP2022533316A5 JP2022533316A5 JP2021563183A JP2021563183A JP2022533316A5 JP 2022533316 A5 JP2022533316 A5 JP 2022533316A5 JP 2021563183 A JP2021563183 A JP 2021563183A JP 2021563183 A JP2021563183 A JP 2021563183A JP 2022533316 A5 JP2022533316 A5 JP 2022533316A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- weight
- formula
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024159726A JP2024170640A (ja) | 2019-05-21 | 2024-09-17 | 食品用ブチレート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175553.7 | 2019-05-21 | ||
| EP19175553 | 2019-05-21 | ||
| PCT/EP2020/064068 WO2020234348A1 (en) | 2019-05-21 | 2020-05-20 | Dietary butyrate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159726A Division JP2024170640A (ja) | 2019-05-21 | 2024-09-17 | 食品用ブチレート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533316A JP2022533316A (ja) | 2022-07-22 |
| JP2022533316A5 true JP2022533316A5 (https=) | 2023-05-16 |
| JP7558193B2 JP7558193B2 (ja) | 2024-09-30 |
Family
ID=66625823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563183A Active JP7558193B2 (ja) | 2019-05-21 | 2020-05-20 | 食品用ブチレート |
| JP2024159726A Pending JP2024170640A (ja) | 2019-05-21 | 2024-09-17 | 食品用ブチレート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159726A Pending JP2024170640A (ja) | 2019-05-21 | 2024-09-17 | 食品用ブチレート |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220218647A1 (https=) |
| EP (1) | EP3972421A1 (https=) |
| JP (2) | JP7558193B2 (https=) |
| CN (2) | CN113840538B (https=) |
| AU (1) | AU2020278825A1 (https=) |
| BR (1) | BR112021020020A2 (https=) |
| CA (1) | CA3135099A1 (https=) |
| WO (1) | WO2020234348A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3237036A1 (en) * | 2021-11-01 | 2023-05-04 | Bioveritas, Llc | Triglycerides and structured lipids from short- and medium-chain fatty acids |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| US5684016A (en) | 1984-04-12 | 1997-11-04 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency |
| US5662953A (en) * | 1989-09-20 | 1997-09-02 | Nabisco, Inc. | Reduced calorie triglyceride mixtures |
| DK657689D0 (da) * | 1989-12-22 | 1989-12-22 | Novo Nordisk As | Middel med biologisk virkning paa tarmslimhinden |
| US20040086621A1 (en) | 2002-11-06 | 2004-05-06 | Kraft Foods Holdings, Inc. | Reduced calorie fat |
| KR20120058618A (ko) | 2003-01-31 | 2012-06-07 | 다이이찌 산쿄 가부시키가이샤 | 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약 |
| US7981453B2 (en) | 2004-12-29 | 2011-07-19 | Kraft Foods Global Brands Llc | Delivery system for low calorie bulking agents |
| ITFI20050024A1 (it) * | 2005-02-14 | 2006-08-15 | Fernando Cantini | Lipidi per l'alimentazione degli animali |
| WO2009006583A1 (en) | 2007-07-03 | 2009-01-08 | Joslin Diabetes Center, Inc. | Treatment of cardiovascular disease with salicylates |
| EP3296284B1 (en) * | 2008-08-21 | 2021-12-01 | The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health | Non-therapeutical use of hydroxybutyrate ester |
| US20110077300A1 (en) * | 2009-03-26 | 2011-03-31 | Jianping Ye | Metabolic Benefits to Butyrate as a Chronic Diet Supplement |
| CN102366413A (zh) * | 2011-10-10 | 2012-03-07 | 上海交通大学 | 三丁酸甘油酯在制备治疗心血管疾病药物中的用途 |
| CN104862351B (zh) | 2015-05-06 | 2018-04-17 | 江南大学 | 一种含共轭亚油酸的低热量结构脂质的制备方法及应用 |
-
2020
- 2020-05-20 BR BR112021020020A patent/BR112021020020A2/pt unknown
- 2020-05-20 US US17/595,581 patent/US20220218647A1/en active Pending
- 2020-05-20 JP JP2021563183A patent/JP7558193B2/ja active Active
- 2020-05-20 AU AU2020278825A patent/AU2020278825A1/en active Pending
- 2020-05-20 CN CN202080036929.3A patent/CN113840538B/zh active Active
- 2020-05-20 CN CN202510209797.4A patent/CN120154071A/zh active Pending
- 2020-05-20 EP EP20727607.2A patent/EP3972421A1/en active Pending
- 2020-05-20 CA CA3135099A patent/CA3135099A1/en active Pending
- 2020-05-20 WO PCT/EP2020/064068 patent/WO2020234348A1/en not_active Ceased
-
2024
- 2024-09-17 JP JP2024159726A patent/JP2024170640A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singh et al. | Microbial production of docosahexaenoic acid (DHA, C22: 6) | |
| KR100657642B1 (ko) | 에이코사펜타엔산 및/또는 스테아리돈산을 포함하여 이루어지는 오일 | |
| US6479544B1 (en) | Therapeutic combinations of fatty acids | |
| Sanders | Essential and trans-fatty acids in nutrition | |
| HRP20200065T1 (hr) | Upotreba etilnog estera ikozapentaenske kiseline u liječenju hipertrigliceridemije | |
| JP4217798B2 (ja) | 共役リノール酸をベースとする合成トリグリセリドの製造方法 | |
| JP2010540636A5 (https=) | ||
| JPH0232017A (ja) | 精神分裂症および／または関連した晩発性運動障害の治療のための薬剤を製造する方法 | |
| BRPI1015120B8 (pt) | Composto lipídico alfa-substituídos, derivados de ácidos graxos beta-oxo poli-insaturados, composição farmacêutica e lipídica e métodos para produzir composto lipídico e ácido 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaeniloxi)butanóico | |
| JP2005515774A (ja) | 高リノレン酸亜麻 | |
| JP6664328B2 (ja) | エイコサペンタエン酸アルキルエステルを含有する組成物及びその製造方法 | |
| CA2386362C (en) | Nutritional or therapeutic compositions comprising lcpufa for the treatment of anandamide-mediated ailments | |
| JPH0788301B2 (ja) | 記憶喪失の治療または予防用組成物 | |
| JP2010509204A5 (https=) | ||
| JP2022533316A5 (https=) | ||
| JP2723243B2 (ja) | 高度不飽和脂肪酸添加動物飼料 | |
| JP2016501248A5 (https=) | ||
| JP2016501249A5 (https=) | ||
| JP2020182497A5 (https=) | ||
| JP2023521917A5 (https=) | ||
| JPH04500971A (ja) | トリグリセリド、該トリグリセリドを含んでなる栄養組成物および栄養用栄養組成物の使用 | |
| JP2002188096A (ja) | 新規なグリセリドおよびその製造法並びにその用途 | |
| JP2022533315A5 (https=) | ||
| JPWO2022209887A5 (https=) | ||
| Charnock | Gamma-linolenic acid provides additional protection against ventricular fibrillation in aged rats fed linoleic acid rich diets |